18F-fluoride uptake in bone metastasis: morphologic and metabolic analysis on integrated PET/CT

Annals of Nuclear Medicine

Volumn 24, Issue 4, 2010, Pages 241-247

  Kawaguchi, Masashi ^a   Tateishi, Ukihide ^a   Shizukuishi, Kazuya ^a   Suzuki, Akiko ^a   Inoue, Tomio ^a  

^a YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

18F fluoride; Bone metastasis; PET; PET CT; Skeletal imaging

Indexed keywords

FLUORINE 18; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE MARROW; BONE METASTASIS; BREAST CANCER; COLON CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HISTOLOGY; HUMAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OSTEOSCLEROSIS; PAROTID GLAND CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; UTERINE CERVIX CANCER; BONE TUMOR; COMPUTER ASSISTED TOMOGRAPHY; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; SYSTEM ANALYSIS; TRANSPORT AT THE CELLULAR LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; BONE NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SYSTEMS INTEGRATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77954533654     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-010-0363-0     Document Type: Article

References (22)

1. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22:2942-2953
2. Rybak LD, Rosenthal DI. Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med. 2001;45:53-64.
3. Citrin DL, Bessent RG, Greig WR. A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol. 1977;28:107-117
4. Rosenthal DI. Radiologic diagnosis of bone metastases. Cancer. 1997;80:1595-1607
5. Galasko CS, Doyle FH. The detection of skeletal metastases from mammary cancer: a regional comparison between radiology and scintigraphy. Clin Radiol. 1972;23:295-297
6. Lee YT. Bone scanning in patients with early breast carcinoma: should it be a routine staging procedure? Cancer. 1981;47:486-495
7. Sanders TG, Parsons TW 3rd. Radiographic imaging of musculoskeletal neoplasia. Cancer Control. 2001;8:221-231
8. Tryciecky EW, Gottschalk A, Ludema K. Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model. Semin Nucl Med. 1997;27:142-151
9. Coleman RE. Monitoring of bone metastases. Eur J Cancer. 1998;34:252-259
10. Zimmer WD, Berquist TH, McLeod RA, Sim FH, Pritchard DJ, Shives TC, et al. Bone tumors: magnetic resonance imaging versus computed tomography. Radiology. 1985;155:709-718
11. Moon KL Jr, Genant HK, Helms CA, Chafetz NI, Crooks LE, Kaufman L. Musculoskeletal applications of nuclear magnetic resonance. Radiology. 1983;147:161-171
12. Vogler JB 3rd, Murphy WA. Bone marrow imaging. Radiology. 1988;168:679-693
13. Cook GJ, Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer. 2000;88:2927-2933
14. Moon DH, Maddahi J, Silverman DH, Glaspy JA, Phelps ME, Hoh CK. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med. 1998;39:431-435
15. Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008;49:68-78.
16. Hawkins RA, Choi Y, Huang SC, Hoh CK, Dahlbom M, Schiepers C, et al. Evaluation of skeletal kinetics of fluorine 18-fluoride ion and PET. J Nucl Med. 1992;33:633-642
17. Even-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H, et al. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med. 2004;45:272-278
18. mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006;47:287-297
19. Schirrmeister H, Guhlmann A, Elsner K, Kotzerke J, Glatting G, Rentschler M, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med. 1999;40:1623-1629
20. Schirrmeister H, Guhlmann A, Kotzerke J, Santjohanser C, Kühn T, Kreienberg R, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol. 1999; 17:2381-2389
21. Schirrmeister H, Glatting G, Hetzel J, Nüssle K, Arslandemir C, Buck AK, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and 18F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001;42:1800-1804
22. Schirrmeister H, Buck A, Guhlmann A, Reske SN. Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography. Thyroid. 2001;11:677-683